NECFA
HURA

New England Capital Financial Advisors’s TuHURA Biosciences HURA Stock Holding History

New England Capital Financial Advisors’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658 Hold
281
– – ﹤0.01% 393
2026
Q1 		$503 Buy
281
+79
+39% +$97 ﹤0.01% 394
2025
Q4 		$153 Hold
202
– – ﹤0.01% 406
2025
Q3 		$501 Hold
202
– – ﹤0.01% 388
2025
Q2 		$452 Buy
+202
New +$682 ﹤0.01% 387

Other funds holding HURA

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $122M AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

New England Capital Financial Advisors's HURA Position: Q2 2026 in Review

New England Capital Financial Advisors held its TuHURA Biosciences (HURA) position steady in Q2 2026 at 281 shares worth $658. The position accounts for ﹤0.01% of the portfolio, ranked #393.

New England Capital Financial Advisors first reported a position in HURA in Q2 2025 and has held it in 5 quarters since. 17 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • New England Capital Financial Advisors held 281 shares of TuHURA Biosciences worth $658 as of Q2 2026.
  • New England Capital Financial Advisors left its TuHURA Biosciences share count unchanged in Q2 2026.
  • TuHURA Biosciences made up ﹤0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #393 holding.
  • New England Capital Financial Advisors first reported a position in TuHURA Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 17 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.